In-Vitro Tissue Platforms & Services

About Frontier Bio

Frontier Bio is a private, pre-clinical stage biotech company pioneering advanced tissue engineering solutions. Its core strategy is dual-pronged: commercializing human-based in-vitro tissue models and services for research and drug development, while advancing its flagship program of a living, patient-specific vascular graft for surgical applications. The company is positioned at the convergence of two significant market shifts: the regulatory push to reduce animal testing and the urgent, unmet clinical need for durable vascular grafts and, ultimately, transplantable organs. Leadership comprises serial entrepreneurs and PhD-level scientists with deep expertise in bioprinting, vascular engineering, and biomaterials.

Therapeutic Areas